Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients
- PMID: 25711638
- PMCID: PMC4365990
- DOI: 10.1167/iovs.14-16065
Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients
Abstract
Purpose: Familial exudative vitreoretinopathy (FEVR) is a developmental disease that can cause visual impairment and retinal detachment at a young age. Four genes involved in the Wnt signaling pathway were previously linked to this disease: NDP, FDZ4, LRP5, and TSPAN12. Identification of novel disease-causing alleles allows for a deeper understanding of the disease, better molecular diagnosis, and improved treatment.
Methods: Sequencing libraries from 92 FEVR patients were generated using a custom capture panel to enrich for 163 known retinal disease-causing genes in humans. Samples were processed using next generation sequencing (NGS) techniques followed by data analysis to identify and classify single nucleotide variants and small insertions and deletions. Sanger validation and segregation testing were used to verify suspected variants.
Results: Of the cohort of 92, 45 patients were potentially solved (48.9%). Solved cases resulted from the determination of 49 unique mutations, 41 of which are novel. Of the novel variants discovered, 13 were highly likely to cause FEVR due to the nature of these variants (frameshifting indels, splicing mutations, and nonsense variants types). To our knowledge, this is the largest study of a FEVR cohort using NGS.
Conclusions: We were able to determine probable disease-causing variants in a large number of FEVR patients, the majority of which were novel. Knowledge of these variants will help to further characterize and diagnose FEVR.
Keywords: FEVR; familial segregation; next-generation sequencing; novel alleles.
Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.
Figures








References
-
- Shimouchi A, Takahashi A, Nagaoka T, Ishibazawa A, Yoshida A. Vitreomacular interface in patients with familial exudative vitreoretinopathy. Int Ophthalmol. 2013; 33: 711–715. - PubMed
-
- Toomes C, Bottomley HM, Scott S, et al. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004; 45: 2083–2090. - PubMed
-
- Drenser KA, Dailey W, Vinekar A, Dalal K, Capone A, Trese MT. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. Arch Ophthalmol. 2009; 127: 1649–1654. - PubMed
-
- Boonstra FN, van Nouhuys CE, Schuil J, et al. Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2009; 50: 4379–4385. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32EY07102/EY/NEI NIH HHS/United States
- 1S10RR026550/RR/NCRR NIH HHS/United States
- P30 EY022589/EY/NEI NIH HHS/United States
- U54 HD083092/HD/NICHD NIH HHS/United States
- R01EY018571/EY/NEI NIH HHS/United States
- S10 RR026550/RR/NCRR NIH HHS/United States
- R01 EY022356/EY/NEI NIH HHS/United States
- P30EY022589/EY/NEI NIH HHS/United States
- TL1 TR000098/TR/NCATS NIH HHS/United States
- R01 EY018571/EY/NEI NIH HHS/United States
- TL1TR00098/TR/NCATS NIH HHS/United States
- R01EY022356/EY/NEI NIH HHS/United States
- T32 EY007102/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources